Quantitative survey into value clarification of discussed treatment options among patients treated for basal‐cell carcinoma

Abstract

There are many effective treatment options for basal‐cell carcinoma (BCC). To ensure a shared treatment decision, it is essential to understand patient preferences, values, and experience with treatments. We evaluated patients' recollections of the treatment choices for their BCC and what kind of information they valued most by doing a quantitative survey via the largest Dutch patient federation ('Patiëntenfederatie Nederland', PFN). The PFN includes a 25,000 member patient‐panel; their medical history is not reported. A survey was developed by the Dermatology department of the Maastricht University Medical Center in collaboration with BCC

This article is protected by copyright. All rights reserved.

http://bit.ly/2Qr9zX8